Cargando…
Low‐dose irradiated mesenchymal stromal cells break tumor defensive properties in vivo
Solid tumors, including gliomas, still represent a challenge to clinicians and first line treatments often fail, calling for new paradigms in cancer therapy. Novel strategies to overcome tumor resistance are mainly represented by multi‐targeted approaches, and cell vector‐based therapy is one of the...
Autores principales: | Stefani, Francesca Romana, Eberstål, Sofia, Vergani, Stefano, Kristiansen, Trine A., Bengzon, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220775/ https://www.ncbi.nlm.nih.gov/pubmed/29752716 http://dx.doi.org/10.1002/ijc.31599 |
Ejemplares similares
-
Identification of two distinct mesenchymal stromal cell populations in human malignant glioma
por: Svensson, Andreas, et al.
Publicado: (2016) -
Low‐dose aspirin and risk of gastric and oesophageal cancer: A population‐based study in the United Kingdom using The Health Improvement Network
por: García Rodríguez, Luis A., et al.
Publicado: (2020) -
The impact of the COVID‐19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020
por: Johansson, Anna L. V., et al.
Publicado: (2022) -
Application of Laser Micro-irradiation for Examination of Single and Double Strand Break Repair in Mammalian Cells
por: Holton, Nathaniel W, et al.
Publicado: (2017) -
Immunogenicity of two doses of BNT162b2 and mRNA‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV‐2 infection
por: La Verde, Nicla, et al.
Publicado: (2022)